Advertisement Details
2019Back
CJC-1295 Without DAC

CJC-1295 Without DAC

Section 8 of Luojia Village, Fuyi Road, Dalong Street, Panyu District, Guangzhou – Guangzhou – China, Guandong18102676775Facebook
Twitter
http://gztengyue.en.made-in-china.com/
Industry > Medical, Pharmaceutical, veterinary products, Laser Surgery...
Source
Guangzhou.
50 Crossingssee all
Guangzhou (China, Guandong) - Aalborg (Denmark)Guangzhou (China, Guandong) - Anderlecht (Belgium)
Guangzhou (China, Guandong) - Limassol (Cyprus)Guangzhou (China, Guandong) - Brno (Czech Republic)
Guangzhou (China, Guandong) - Dubrovnik (Croatia)Guangzhou (China, Guandong) - Graz (Austria)
Guangzhou (China, Guandong) - Burgas (Bulgaria)
Description

Product Description

CJC-1295 Without DAC


Alias: CJC-1295 Acetate; CJC1295(Without DAC)

Cas No.: 863288-34-0
Molecular Formula: C165H271N47O46
Molecular Weight: 3649.30
Purity (HPLC): 98.0%
Single Impurity(HPLC): 1.0%
Amino Acid Composition: 10% of theoretical
Peptide Content(N%): 80%(by %N)
Water Content(Karl Fischer): 6.0%

MS(ESI): N/A
Mass Balance: 95.0~105.0%
CJC-1295 DAC vs. CJC-1295 No DAC
CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse of Human .
HS: 2922199090
Packing: 2mg/vial,10vials/kit
Appearance: White powder
Usage: Pharmaceutical intermediates
Product description:


Product name
CJC-1295 DAC
Purity 99%
Forms 1mg/2mg/5mg/vial,10vial/box
Min order 10g
Packing Foil bag or tin
Appearance White crystalline powder

Trade
Alliance
Include thirds
Send message
Follow user
Multimedia files
CJC-1295 Without DAC
Comments
New Comment
Submit